Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $48.39 USD
Change Today -1.20 / -2.43%
Volume 2.8M
As of 1:19 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Coury

Executive Chairman and Chairman of Executive Committee,Mylan N.V.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Robert J. Coury has been an Executive Chairman of Mylan N.V. since January 1, 2012 and has been its Director since February 1, 2002. Under his visionary leadership, Mylan transformed from the third largest generics pharmaceutical company in the U.S. into one of the largest pharmaceutical companies in the world, earning spots in both the S&P 500 and the Fortune 500. Mr. Coury served as the Chief Executive Officer of Mylan N.V. from September 2002 to January 1, 2012 ...

Read Full Background

Corporate Headquarters*

Albany Gate
Potters Bar, Hertfordshire EN6 1AG

United Kingdom

Phone: 44 1707 853000
Fax: 44 1707 643148

Board Members Memberships*

Executive Chairman and Chairman of Executive Committee


BS 1984
University of Pittsburgh

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,350,000

Stock Options*

Restricted Stock Awards$4,320,005
All Other Compensation$883,086
Exercised Options165,700
Exercised Options Value$5,387,061
Exercisable Options965,728
Unexercisable Options1,252,473
Total Value of Options$5,387,061
Total Number of Options2,383,901

Total Compensation*

Total Annual Cash Compensation$5,289,149
Total Short Term Compensation$1,350,000
Other Long Term Compensation$5,203,091
Total Calculated Compensation$22,523,590
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYL:US $48.36 USD -1.23


Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
James T. Ryan Chairman, Chief Executive Officer and President
W.W. Grainger, Inc.
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
Stanley M. Bergman Executive Chairman and Chief Executive Officer
Henry Schein, Inc.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYLAN NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at